Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Thank You!

    Your message has been sent.

    Oops, message not sent.

    Please make sure fields are complete.

    Uncategorized Posts

    Holiday Letter from the Snyder Family

    December 23rd, 2020
    >  > Snyder Family Holiday Letter 2020 > > > Merry Christmas and Happy Holidays from the Snyder family in Albuquerque, New Mexico! Like you and yours, we’ve had a year at Casa Del Snyder where the only constants has been the…

    Read Article

    Tibsovo: Ivosidenib Generates Interest in the Business World


    Agios to Sell Cancer Portfolio to Servier for $1.8 Billion By Emma Court December 21, 2020, 7:00 AM EST Updated on December 21, 2020, 10:18 AM EST Agios Pharmaceuticals Inc. said it agreed to sell its portfolio of oncology drugs to Servier…

    Read Article

    Help Us Get The Word Out: February 6 is Chondrosarcoma Awareness Day

    December 10th, 2020

    Read Article

    Virtual Dialogue: Straight Talk About Chondrosarcoma Videos Are Posted On-line: csfshayna.org

    December 1st, 2020
    On November 17, 2020 the Chondrosarcoma CS Foundation, Inc. held its first International Virtual Dialogue entitled: Straight Talk About Chondrosarcoma. There were 109 registrations and at one time we had over 80 participants attend the Virtual…

    Read Article

    Message from A CS Warrior: David Bowles

    November 26th, 2020
    Hello fellow warriors….well some good news for all of us: I spoke today via video with a doc whose advice I get every 3 months when my CT scans are done, Jonathan Trent MD, Ph.D. (how’s that for qualified??) He runs a clinical trial for CS which…

    Read Article

    CS Patient Response to Dulanermin a Dual Proapoptotic Receptor (DR4/DR5)


    Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist Vivek Subbiah 1, Robert E Brown, Jamie Buryanek, Jonathan Trent, Avi Ashkenazi, Roy Herbst, Razelle…

    Read Article

    New Type of Immunotherapy


    New type of immunotherapy may pave the way for better cancer treatments by Karolinska Institutet From left: First author Silke Eisinger and last author Mikael Karlsson from Karolinska Institutet in Sweden. Credit: Mitch Eisinger Immunotherapy for…

    Read Article

    SARCOMA: SEARCHING FOR CAUSES AND CURES

    November 18th, 2020
    Karina Galoian, Ph.D., is a research associate professor in the Department of Orthopaedics at the University of Miami Leonard M. Miller School of Medicine. She also leads the departmental Institutional Review Board and is Research Director of the…

    Read Article

    Virtual Dialogue Zoom Meeting URL

    November 17th, 2020
    Last Reminder. We go live at 7:15PM EST (New York time) tonight. We noticed that several of you have tested the connection and are ready to go. If you have any difficulties, Text me at 301-404-7100 We have 109 registrations. Looking forward to…

    Read Article

    Virtual Dialogue has 93 Registrations Far Exceeding Expectations

    November 13th, 2020
    In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group…

    Read Article

    Contact Information


    If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

    **A Registered 501c3 Non-Profit Charity Organization. All donations are tax-deductible.**

    Send a Message